NCT05891431 · ACTIVE NOT RECRUITING
Engagement and Acceptability of the Untire mHealth App
This trial is testing a mobile app called Untire, designed to help adults with cancer-related fatigue. Researchers want to know whether people actually use the app, whether they find it acceptable, and whether it reduces fatigue or improves quality of life over 12 weeks. It is a Phase NA study, meaning this is more of a feasibility and early-efficacy check than a rigorous controlled trial of an already-promising treatment.
You may qualify if
- Adults with cancer or cancer survivors (18 years and older).
- Self-reported current diagnosis or previous history of treatment for cancer (cancer survivor).
- A moderate or severe level of fatigue as measured by items 1-3 of the Brief Fatigue Inventory (BFI).
- Access to a smart phone, tablet, or iPad (Apple or Android).
You're excluded if
- Participants \< 18 years of age
- Non-English language speakers
- Participants with a diagnosis of and receiving treatment for severe psychological distress (e.g. major depression, psychotic disorder, anxiety disorder, or addiction).
- Participants with a diagnosis of chronic fatigue syndrome, myalgic encephalomyelitis, or fibromyalgia.
- Previous or current us of the Untire app
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-09-19